US, Gilead announce settlement in HIV pre-exposure prophylaxis patent case
MLex Summary: The US, Gilead Sciences and its wholly-owned subsidiary Gilead Sciences Ireland UC, or GSIUC, jointly moved to withdraw proceedings at the US Court of Appeals for the Federal Circuit...To view the full article, register now.
Already a subscriber? Click here to view full article